Literature DB >> 8675319

Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine.

M Lebens1, V Shahabi, M Bäckström, T Houze, N Lindblad, J Holmgren.   

Abstract

Three variants of the cholera toxin B subunit (CTB) were generated by site-specific mutagenesis in which regions of the mature protein were altered to the composition found at the corresponding positions of the closely related B subunit of the heat-labile enterotoxin of enterotoxigenic Escherichia coli (LTB). The mutant proteins were expressed in Vibrio cholerae and purified from the growth medium. In the first of the mutant proteins, the first 25 amino acids corresponded to the sequence found in LTB, and in the second, changes were made at positions 94 and 95 of the mature protein. The third mutant protein combined the changes made in the first two. Analysis of the immunological properties of these novel proteins by using monoclonal antibodies and absorbed polyclonal antiserum demonstrated that they had acquired LTB-specific epitopes. Immunizations with the mutant proteins resulted in antisera containing LTB-specific as well as CTB-specific and cross-reactive antibodies. The sera were also found to be more strongly cross-reactive in the in vitro neutralization of both cholera toxin and heat-labile enterotoxin than were antisera raised against either CTB or LTB. The results suggest that such hybrid CTB-LTB proteins may be useful in a broad-spectrum vaccine against enterotoxin-induced diarrhea.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675319      PMCID: PMC174048          DOI: 10.1128/iai.64.6.2144-2150.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  An oral B subunit: whole cell vaccine against cholera.

Authors:  J Holmgren; A M Svennerholm; M Jertborn; J Clemens; D A Sack; R Salenstedt; H Wigzell
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

Authors:  H Peltola; A Siitonen; H Kyrönseppä; I Simula; L Mattila; P Oksanen; M J Kataja; M Cadoz
Journal:  Lancet       Date:  1991-11-23       Impact factor: 79.321

3.  Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.

Authors:  J Sanchez; J Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes.

Authors:  A M Svennerholm; L Gothefors; D A Sack; P K Bardhan; J Holmgren
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

5.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 6.  Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin.

Authors:  B D Spangler
Journal:  Microbiol Rev       Date:  1992-12

7.  Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial.

Authors:  J D Clemens; D A Sack; J R Harris; J Chakraborty; P K Neogy; B Stanton; N Huda; M U Khan; B A Kay; M R Khan
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

8.  Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli.

Authors:  T K Sixma; S E Pronk; K H Kalk; E S Wartna; B A van Zanten; B Witholt; W G Hol
Journal:  Nature       Date:  1991-05-30       Impact factor: 49.962

9.  Alterations at the carboxyl terminus change assembly and secretion properties of the B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  M Sandkvist; T R Hirst; M Bagdasarian
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

10.  Identification of errors among database sequence entries and comparison of correct amino acid sequences for the heat-labile enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  M Domenighini; M Pizza; M G Jobling; R K Holmes; R Rappuoli
Journal:  Mol Microbiol       Date:  1995-03       Impact factor: 3.501

View more
  15 in total

1.  Vaccines against gastroenteritis, current progress and challenges.

Authors:  Hyesuk Seo; Qiangde Duan; Weiping Zhang
Journal:  Gut Microbes       Date:  2020-06-18

2.  Cloning, expression, purification and preliminary X-ray diffraction studies of a novel AB₅ toxin.

Authors:  Natasha Ng; Dene Littler; Jérôme Le Nours; Adrienne W Paton; James C Paton; Jamie Rossjohn; Travis Beddoe
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-07-27

3.  Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in Bangladesh.

Authors:  Fahima Chowdhury; Yasmin A Begum; Mohammad Murshid Alam; Ashraful I Khan; Tanvir Ahmed; M Saruar Bhuiyan; Jason B Harris; Regina C LaRocque; Abu S G Faruque; Hubert Endtz; Edward T Ryan; Alejandro Cravioto; Ann-Mari Svennerholm; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

4.  Construction of a multihybrid display system: flagellar filaments carrying two foreign adhesive peptides.

Authors:  J Tanskanen; T K Korhonen; B Westerlund-Wikström
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

5.  Protective immunity of microsphere-based mucosal vaccines against lethal intranasal challenge with Streptococcus pneumoniae.

Authors:  S Y Seong; N H Cho; I C Kwon; S Y Jeong
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler's diarrhea.

Authors:  S Karaman; J Cunnick; K Wang
Journal:  Plant Cell Rep       Date:  2011-09-22       Impact factor: 4.570

Review 7.  From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.

Authors:  Ann-Mari Svennerholm
Journal:  Indian J Med Res       Date:  2011-02       Impact factor: 2.375

8.  No direct binding of the heat-labile enterotoxin of Escherichia coli to E. coli lipopolysaccharides.

Authors:  Lena Jansson; Jonas Angström; Michael Lebens; Susann Teneberg
Journal:  Glycoconj J       Date:  2009-10-21       Impact factor: 2.916

9.  The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens.

Authors:  Susannah Leach; John D Clements; Joanna Kaim; Anna Lundgren
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Microwave-assisted Cu(I)-catalyzed, three-component synthesis of 2-(4-((1-phenyl-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-1H-benzo[d]imidazoles.

Authors:  Yogesh Kumar; Vijay Bahadur; Anil Kumar Singh; Virinder Singh Parmar; Erik V Van der Eycken; Brajendra Kumar Singh
Journal:  Beilstein J Org Chem       Date:  2014-06-24       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.